{ "Web-based Decision Aid for Genomic Test Results in Cholangiocarcinoma, Colorectal Cancer, and Multiple Myeloma", "This study is testing a web-based tool called Genetics Advisor Decision Aid to help you decide what types of genomic (genetic) test results you want to receive. It's compared to standard materials that explain your choices. This study is for adults aged 18 and older who have cholangiocarcinoma, or who are African American with multiple myeloma, or who are African American and 65 or older with colorectal cancer. You must already be enrolled in the WU-PE-CGS study (NCT06340646). Researchers will measure how confident you feel about making decisions about your genomic test results at the start, after using the materials, and three months later. The current status of this study is unclear, and it plans to enroll 240 participants.", "design": "This is an interventional study, meaning participants will receive a specific intervention. It is a randomized control trial, comparing the Genetics Advisor Decision Aid to standard materials.", "commitments": "You will be given access to either the Genetics Advisor Decision Aid or standard materials. Your self-efficacy (confidence) about genomic test results will be measured at the start, after viewing the materials, and again after three months.", "compensation": "Not stated in the trial record.", "follow_up": "Your self-efficacy will be measured at three months after enrollment.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.